The anatomic basis of maternal serum screening

Area of Science:

• Perinatal Medicine
• Biochemical Markers
• Fetal Development

Background:

• Maternal serum alpha fetoprotein (AFP) levels are crucial in prenatal diagnostics.
• Elevated AFP can indicate fetal abnormalities or placental complications.
• Understanding AFP's pathways into maternal circulation is key.

Purpose of the Study:

• To investigate the distinct pathways of fetal serum markers, specifically alpha fetoprotein (AFP), into maternal circulation.
• To explore the potential for identifying the source of elevated maternal serum AFP based on its origin.

Main Methods:

• Review of anatomic pathology observations regarding AFP's traversal.
• Analysis of AFP's entry into amniotic fluid versus maternal circulation via placental villi.
• Hypothesizing biochemical markers based on identified pathways.

Main Results:

• Fetal AFP reaches maternal serum via amniotic fluid or directly through the placental villi.
• AFP enters amniotic fluid through fetal body wall defects or urine.
• Placental AFP leakage is associated with villous hemorrhage or injury.

Conclusions:

• Distinct pathways for AFP entry suggest different underlying causes for elevated maternal serum AFP.
• Biochemical markers may differentiate between fetal and placental sources of AFP.
• Anatomic pathology insights can guide the search for diagnostic biochemical markers.